£325.00

The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean

Price data last checked 88 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 3 days • 3 data points (No recent data available)

Historical
Generating forecast...
£325.00 £308.75 £315.25 £321.75 £328.25 £334.75 £341.25 26 January 2026 26 January 2026 27 January 2026 27 January 2026 28 January 2026

Price Distribution

Price distribution over 3 days • 1 price levels

Days at Price
3 days 0 1 2 2 3 £325 Days at Price

Price Analysis

Most common price: £325 (3 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 3 days

Product Specifications
Format
Paperback
ASIN
B00E4Z28J8
Category
Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
24 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana
98% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana

£325.00 28 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America
98% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America

£325.00 29 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe
98% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe

£325.00 24 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Africa & the Middle East
98% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Africa & the Middle East

£325.00 24 Jan 2026
The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean
97% match

The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean

£325.00 26 Mar 2026
The 2013-2018 Outlook for Psoriasis Drugs in North America & the Caribbean
97% match

The 2013-2018 Outlook for Psoriasis Drugs in North America & the Caribbean

£325.00 28 Jan 2026
The 2013-2018 Outlook for Ophthalmic Pharmaceutical Drugs in North America & the Caribbean
96% match

The 2013-2018 Outlook for Ophthalmic Pharmaceutical Drugs in North America & the Caribbean

£325.00 28 Jan 2026
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean
96% match

The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean

£325.00 31 Mar 2026
The 2013-2018 Outlook for Renal Cell Carcinoma (RCC) Drugs in the United States
96% match

The 2013-2018 Outlook for Renal Cell Carcinoma (RCC) Drugs in the United States

£495.00 23 Jan 2026
The 2013-2018 Outlook for Erythropoietins in North America & the Caribbean
96% match

The 2013-2018 Outlook for Erythropoietins in North America & the Caribbean

£325.00 21 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
96% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East

£325.00 25 Mar 2026
The 2013-2018 Outlook for Small Molecule Kinase Inhibitors in North America & the Caribbean
96% match

The 2013-2018 Outlook for Small Molecule Kinase Inhibitors in North America & the Caribbean

£325.00 29 Jan 2026
The 2013-2018 Outlook for Biotechnology Reagents in North America & the Caribbean
95% match

The 2013-2018 Outlook for Biotechnology Reagents in North America & the Caribbean

£325.00 09 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia
95% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia

£325.00 31 Jan 2026
The 2013-2018 Outlook for Anticoagulants in North America & the Caribbean
95% match

The 2013-2018 Outlook for Anticoagulants in North America & the Caribbean

£325.00 22 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
95% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 31 Mar 2026
The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa
95% match

The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa

£325.00 06 Feb 2026
The 2013-2018 Outlook for E-Prescription Systems in North America & the Caribbean
95% match

The 2013-2018 Outlook for E-Prescription Systems in North America & the Caribbean

£325.00 17 Feb 2026
The 2013-2018 Outlook for Chiral Technologies in North America & the Caribbean
95% match

The 2013-2018 Outlook for Chiral Technologies in North America & the Caribbean

£325.00 06 Feb 2026
The 2013-2018 Outlook for Polymerase Chain Reaction (PCR) Technologies in North America & the Caribbean
95% match

The 2013-2018 Outlook for Polymerase Chain Reaction (PCR) Technologies in North America & the Caribbean

£325.00 01 Feb 2026
The 2013-2018 Outlook for Allergy Drugs in North America & the Caribbean
95% match

The 2013-2018 Outlook for Allergy Drugs in North America & the Caribbean

£325.00 11 Jan 2026
The 2013-2018 Outlook for Sleeping Pills in North America & the Caribbean
95% match

The 2013-2018 Outlook for Sleeping Pills in North America & the Caribbean

£325.00 12 Jan 2026
The 2013-2018 Outlook for Pipettes and Pipettors in North America & the Caribbean
95% match

The 2013-2018 Outlook for Pipettes and Pipettors in North America & the Caribbean

£325.00 24 Jan 2026
The 2013-2018 Outlook for Phytosterols in North America & the Caribbean
95% match

The 2013-2018 Outlook for Phytosterols in North America & the Caribbean

£325.00 23 Jan 2026